15-20% of patients with stage II colon cancer will develop recurrence of disease after curative surgery. The aim of this thesis was to identify biomarkers in colon cancer tissue at any molecular level that may help to identify these patients, thereby enabling a more personalized treatment.

Additional Metadata
Keywords Colon cancer, Molecular biomarker, Prognostication, RNA seq, RT-qPCR, Observational cohort studies
Promotor J.N.M. IJzermans (Jan) , J.W.M. Martens (John)
Publisher Erasmus University Rotterdam
ISBN 978-94-6295-826-5
Persistent URL hdl.handle.net/1765/104031
Citation
Coebergh van den Braak, R.R.J. (2018, January 31). Colon cancer : the clinical significance of molecular biomarkers. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/104031